Vietnam is expected to produce six-in-one vaccines in 2017 or 2018 and by 2020 these will be used widely in the country, according to the Ministry of Health.
Hanoi (VNA) -Vietnam is expected to produce six-in-one vaccines in 2017 or 2018 and by 2020these will be used widely in the country, according to the Ministry of Health. Vietnam already manufactures11 out of 12 vaccines used in the nationwide expanded free immunisationprogramme for children, including vaccines against tuberculosis, diphtheria,whooping cough, tetanus, measles, poliomyelitis, hepatitis B, Japanesemeningitis B, cholera, typhoid and rubella. In November 2016,Vietnam announced the successful production of a measles-rubella vaccine (MR)for the first time. Vietnam is one of only25 countries in the world that can produce vaccines and is the fourth in Asiato manufacture the MR vaccine, following Japan, India, and China, the Nhan Dan(People) weekly reported. This is the first vaccinethat has been produced in Vietnam by the health ministry’s Centre for Researchand Production of Vaccines and Biology (POLYVAC) under a technology-transferproject launched by the Japan International Co-operation Agency (JICA). In 2015, the WHOcertified that Vietnam has a fully-equipped national regulatory authority (NRA)system that ensures the safety and efficacy of vaccines produced and used inVietnam. Deputy Health MinisterNguyen Thanh Long said the NRA achievement would open up opportunities for Vietnamto export vaccines and contribute in the fight against global epidemics.
In a recent NRAassessment, the WHO said that four of Vietnam’s vaccines ─ Japanese Bencephalitis, measles, hepatitis A, and hepatitis B ─ can apply for WHOpre-appraisal before being sold in bulk to international organisations. Local vaccinemanufacturing facilities can currently supply enough doses for both domesticneeds and export𝔉 demand.
In recent years, theCompany for Vaccine and Biological Production No.1 (VABIOTECH) has exportedover three million doses of Japanese B encephalitis vaccine to India. Japaneseencephalitis vaccines are also penetrating the market of East Timor. Inaddition, 32,000 doses of hepatitis A vaccine have been exported to theRepublic of Korea and 115,000 doses of oral cholera vaccine to Sri Lanka, thePhilippines and India. Vietnam currently hasfour factories producing vaccines, using equipment and technology that meetsCGMP-WHO standards: VABIOTECH; Pasteur Da Lat Vaccine Company (DAVAC); POLYVAC;and the Institute of Vaccines and Medical Biologicals (IVAC). However, challengesremain ahead for the vaccine production. Việt Nam is able to produce onlysingle vaccines or certain types of material for mixed vaccines (multi-functionvaccines that have from four to six vaccines in one dose). In 2019, Việt Nam willno longer receive support from the Global Alliance for Vaccines and Immunization(GAVI) in regard to the five-in-one vaccine that protects people fromdiphtheria, tetanus, whooping cough, polio, and Hib disease. The health sector ismaking efforts to produce five-in-one and six-in-one vaccines but is stillencountering difficulties relating to technology and capital. Deputy Minister Longsaid the research and production of five-in-one and six-in-one vaccines wasamong the top priorities of the country, and urged the supply of improvedtechnology to produce such vaccines.-VNA
Vietnam has successfully produced a combined measles-rubella vaccine as part of a project with co-operation from the Japan International Co-operation Agency (JICA).
The measles-rubella vaccine (MR) produced by Vietnam, which was clinically tested and proven safe and effective, will be used in the National Expanded Programme on Immunisation free of charge in 2017.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Source: VNA) 
